Massachusetts Medical Society

Parent Organization: American Medical Assn

The Massachusetts Medical Society (MMS) is the oldest continuously-operating state medical society in the United States. Incorporated on November 1, 1781, by an act of the Massachusetts General Court, the MMS is a non-profit organization that consists of approximately 22,000 physicians, medical students and residents. It is currently based in Waltham, Massachusetts. The majority of the members live or practice in Massachusetts and the immediate vicinity.

Source: Wikipedia

Campaign Finance

$500 Given
Information

Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:

  • contributions under $200 are not reported, and so are not included in totals.
  • only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
  • contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
  • corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
  • organization totals include known subsidiaries of the organization.

For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.

covers through 2011

  • Top Recipients

    Employee Color Block
    Individuals
    PAC Color Block
    PAC
    Includes contributions from the organization’s employees, their family members, and its political action committee.

  • Republicans vs. Democrats

    in dollars

  • State vs. Federal

    in dollars
View all campaign finance data for Massachusetts Medical Society Sources: OpenSecrets.org

Lobbying

$210,000 Spent
Information

Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.

For more information, please see our lobbying methodology page.

covers through Q3, 2011

Lobbying On Behalf of Massachusetts Medical Society

  • Names of Lobbyists
  • Most Frequently Disclosed Lobbying Issues
    • Health Issues,
    • Medicare & Medicaid,
    • Torts,
    • Insurance,
    • Labor, Antitrust & Workplace,
    • Pharmacy
View all lobbying data for Massachusetts Medical Society Sources: OpenSecrets.org

Regulations

9 Mentions; 1 Submissions
Information

All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.

Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.

Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.

Regulations and public comments can be downloaded in bulk here.

updated from Regulations.gov on September 27, 2011

The tables show occurrences of "Massachusetts Medical Society" in public comments on proposed federal regulations.

  • Documents Submitted by the Organization
    • Submissions
    • Agency
    • Docket
    • Date
    • Toggle 2 FDA Food Labeling; Nutrition Labeling of Standard Menu Items in Restaurants and Similar Retail Food Establishments 2011
  • Mentions in Document Text
    • Mentions
    • Agency
    • Docket
    • Date
    • Toggle 3 EPA Deferral of Application of the Prevention of Significant Deterioration (PSD) and Title V Programs to CO2 emissions from Bioenergy and Other Biogenic Sources 2011
    • Toggle 2 FDA Food Labeling; Nutrition Labeling of Standard Menu Items in Restaurants and Similar Retail Food Establishments 2011
    • Toggle 1 EPA Standards of Performance for Fossil-Fuel-Fired, Electric Utility, Industrial-Commercial-Institutional, and Small Industrial-Commercial-Institutional Steam Generating Unit 2011
    • Toggle 1 FDA Refrain from Approving Any Abbreviated New Drug Application for Which Dovonex® Cream (calcipotriene 0.005%) is The Reference Listed Drug Until Certain Conditions Are Satisfied 2011
    • Toggle 1 FDA Refrain From Approving any Abbreviated New Drug Application (ANDA) for Which Taclonex® Ointment (Calcipotriene 0.005% and Betamethasone Dipropionate 0.064%) and Taclonex Scalp® Topical Suspension (Calcipotriene 0.005% and Betamthasone Dipropionate 0.064%) is the Reference List Drug (RLD) Until the Following Conditions are Satisfied 2011
    • Toggle 1 CMS Changes to the Electronic Prescribing (eRx) Incentive Program 2011
    • Toggle 1 CMS Methods for Assuring Access to Covered Medicaid Services (CMS-2328-P) 2011
    • Toggle 1 EPA Integrated Science Assessment for Ozone and Other Photochemical Oxidants 2011
    • Toggle 1 CMS Medicare Program: Availability of Medicare Data for Performance Measurement 2011